News - Aeterna Zentaris Inc. and EMD Serono, Inc., the U.S. and Canadian biopharmaceutical businesses of Merck KGaA, Darmstadt, Germany, today announced the finalization of a promotional services agreement that will allow Aeterna Zentaris to promote Saizen® [somatropin (rDNA origin) for injection] to designated medical professionals in specified territories in the United States. Saizen® is a recombinant human Growth Hormone (r-hGH) registered in the U.S. for the treatment of growth hormone deficiency (GHD) in children and adults.
News - Opsens inc. is pleased to announce the first use of the OptoWire and OptoMonitor, its products to measure Fractional Flow Reserve ("FFR"), by Dr. Nico Pijls in Eindhoven, the Netherlands. Opsens' FFR products are designed to optimize the diagnosis and guide the treatment of patients with coronary heart disease.
News - DiagnoCure Inc.reports that the results of the prospective trial on its prostate cancer panel (PCP) urine test were well received by the urologist community attending the 2015 Annual Meeting of the American Urological Association (AUA) held from May 15 to May 19 in New Orleans, Louisiana.
News - CO2 Solutions Inc., the leader in the field of enzyme-enabled carbon capture technology, today announced that its 10 tonnes per day (tpd) CO2 capture demonstration project at Salaberry-de-Valleyfield, Quebec, has commenced in line with the Company`s timeline as communicated previously.
News - Medicago, a major Canadian biotech company and an international leader in the development and production of plant-based vaccines and therapeutics, is proud to announce that Quebec City will be home to its new production complex. The $245 million project will create 200 new high-skilled jobs by 2019, adding to the team of 180 employees already working at Medicago’s Quebec City office and laboratories. The project is expected to generate more than $461 million in direct and indirect economic benefits over the next five years.
News - The 6th edition of the event Celebrating Partnership was presented by the « Association for the Development of Research and Innovation in Quebec » (ADRIQ) to recognize the achievements of Québec technology collaborations between researchers, entrepreneurs and their partners.
News - B-TEMIA Inc., a market leader in human augmentation, announced the closing of a private placement with a group of Canadian private investors and the Toronto-based private healthcare fund, Epic Capital Management Inc., a boutique investment firm focused on Canadian small and mid-cap securities. This new financing confirms a 60% increase in B-TEMIA's value creation over the last year.
News - At the Canadian Agri-Food Export Cocktail Reception, Malimousse Seafood Dip with Greek yogurt received the 2015 SIAL Innovation Grand Award. Made with Greek Yogurt and Gluten Free, this new dip from Québec City-based Malimousse pleased the jury by its quality, its flavour and its simple list of ingredients.
News - A $19.2M project will provide Quebec City with a new urban science joint research lab around which will be built a world-class open innovation ecosystem in this emerging multidisciplinary field of knowledge. In partnership with Quebec City authorities, Laval University, the National Institute of Scientific Research (INRS), the Quebec Metro High Tech Park and Thales Canada Inc., and with the support of the Government of the Province of Quebec, the Joint Research Unit aims to position the citizen at the center of municipal activities and to design urban science solutions for the future, in areas such as water and power management, urban spaces and infrastructure and individual, asset and data mobility and safety.
News - French multinational OVH, a backronym for “On vous héberge” or “We Host You,” announced on Thursday, April 16, that it had chosen Québec City as the home for its North American R&D centre. The centre will specialize in, among other things, customer experience, and will hire 50 highly skilled employees.